富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/27 | 1,454 | 1,497 | 1,454 | 1,489 | +45 | +3.1% | 123,900 |
| 2024/06/26 | 1,438 | 1,453 | 1,431 | 1,444 | +7 | +0.5% | 109,500 |
| 2024/06/25 | 1,435 | 1,452 | 1,434 | 1,437 | -7 | -0.5% | 139,300 |
| 2024/06/24 | 1,448 | 1,450 | 1,435 | 1,444 | +3 | +0.2% | 91,300 |
| 2024/06/21 | 1,483 | 1,494 | 1,428 | 1,441 | -38 | -2.6% | 118,100 |
| 2024/06/20 | 1,499 | 1,499 | 1,460 | 1,479 | -18 | -1.2% | 85,800 |
| 2024/06/19 | 1,476 | 1,500 | 1,476 | 1,497 | +25 | +1.7% | 73,500 |
| 2024/06/18 | 1,472 | 1,485 | 1,465 | 1,472 | +9 | +0.6% | 62,300 |
| 2024/06/17 | 1,427 | 1,471 | 1,422 | 1,463 | +13 | +0.9% | 122,700 |
| 2024/06/14 | 1,401 | 1,458 | 1,401 | 1,450 | +33 | +2.3% | 111,800 |
| 2024/06/13 | 1,434 | 1,434 | 1,413 | 1,417 | -17 | -1.2% | 76,000 |
| 2024/06/12 | 1,445 | 1,453 | 1,432 | 1,434 | -11 | -0.8% | 65,500 |
| 2024/06/11 | 1,490 | 1,490 | 1,445 | 1,445 | -43 | -2.9% | 69,500 |
| 2024/06/10 | 1,458 | 1,494 | 1,458 | 1,488 | +31 | +2.1% | 67,100 |
| 2024/06/07 | 1,487 | 1,487 | 1,456 | 1,457 | -30 | -2% | 73,800 |
| 2024/06/06 | 1,489 | 1,503 | 1,470 | 1,487 | +6 | +0.4% | 71,800 |
| 2024/06/05 | 1,493 | 1,494 | 1,469 | 1,481 | -13 | -0.9% | 61,000 |
| 2024/06/04 | 1,500 | 1,516 | 1,491 | 1,494 | -16 | -1.1% | 43,500 |
| 2024/06/03 | 1,486 | 1,514 | 1,486 | 1,510 | +25 | +1.7% | 51,600 |
| 2024/05/31 | 1,458 | 1,491 | 1,458 | 1,485 | +27 | +1.9% | 88,100 |
| 2024/05/30 | 1,442 | 1,458 | 1,433 | 1,458 | +1 | +0.1% | 57,000 |
| 2024/05/29 | 1,470 | 1,477 | 1,457 | 1,457 | -17 | -1.2% | 42,100 |
| 2024/05/28 | 1,500 | 1,500 | 1,464 | 1,474 | -26 | -1.7% | 93,900 |
| 2024/05/27 | 1,482 | 1,514 | 1,477 | 1,500 | +23 | +1.6% | 57,100 |
| 2024/05/24 | 1,457 | 1,495 | 1,454 | 1,477 | -6 | -0.4% | 129,400 |
| 2024/05/23 | 1,450 | 1,492 | 1,430 | 1,483 | +41 | +2.8% | 159,100 |
| 2024/05/22 | 1,505 | 1,506 | 1,437 | 1,442 | -76 | -5% | 304,100 |
| 2024/05/21 | 1,516 | 1,539 | 1,515 | 1,518 | ±0 | ±0% | 59,600 |
| 2024/05/20 | 1,513 | 1,545 | 1,510 | 1,518 | -5 | -0.3% | 93,300 |
| 2024/05/17 | 1,517 | 1,534 | 1,505 | 1,523 | +13 | +0.9% | 40,500 |
| 2024/05/16 | 1,530 | 1,530 | 1,501 | 1,510 | -19 | -1.2% | 48,600 |
| 2024/05/15 | 1,520 | 1,544 | 1,516 | 1,529 | +11 | +0.7% | 55,000 |
| 2024/05/14 | 1,530 | 1,530 | 1,503 | 1,518 | -26 | -1.7% | 98,800 |
| 2024/05/13 | 1,560 | 1,562 | 1,491 | 1,544 | -45 | -2.8% | 198,100 |
| 2024/05/10 | 1,481 | 1,615 | 1,478 | 1,589 | +26 | +1.7% | 348,100 |
| 2024/05/09 | 1,612 | 1,612 | 1,557 | 1,563 | -39 | -2.4% | 173,200 |
| 2024/05/08 | 1,601 | 1,604 | 1,586 | 1,602 | +2 | +0.1% | 88,600 |
| 2024/05/07 | 1,609 | 1,609 | 1,585 | 1,600 | -1 | -0.1% | 58,100 |
| 2024/05/02 | 1,606 | 1,607 | 1,591 | 1,601 | +5 | +0.3% | 48,700 |
| 2024/05/01 | 1,577 | 1,605 | 1,575 | 1,596 | +6 | +0.4% | 56,200 |
| 2024/04/30 | 1,571 | 1,596 | 1,558 | 1,590 | +38 | +2.4% | 47,800 |
| 2024/04/26 | 1,542 | 1,556 | 1,536 | 1,552 | +9 | +0.6% | 36,100 |
| 2024/04/25 | 1,570 | 1,570 | 1,543 | 1,543 | -29 | -1.8% | 44,800 |
| 2024/04/24 | 1,572 | 1,578 | 1,558 | 1,572 | +15 | +1% | 57,000 |
| 2024/04/23 | 1,553 | 1,557 | 1,541 | 1,557 | +20 | +1.3% | 66,000 |
| 2024/04/22 | 1,523 | 1,548 | 1,519 | 1,537 | +14 | +0.9% | 66,700 |
| 2024/04/19 | 1,541 | 1,546 | 1,506 | 1,523 | -29 | -1.9% | 79,000 |
| 2024/04/18 | 1,515 | 1,565 | 1,513 | 1,552 | +32 | +2.1% | 60,900 |
| 2024/04/17 | 1,540 | 1,544 | 1,515 | 1,520 | -30 | -1.9% | 93,200 |
| 2024/04/16 | 1,577 | 1,591 | 1,549 | 1,550 | -46 | -2.9% | 166,200 |
101～
150
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 145,800円 | +15.7% | +5.3% | 3.12% | 10.49倍 | 0.78倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| 生化学 | 81,000円 | +10.5% | +169.1% | 3.70% | 12.81倍 | 0.59倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| クオリプス | 518,000円 | +652.2% | - | 0.00% | - | 7.45倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| ダイト | 214,700円 | +4.5% | -10.8% | 3.26% | 14.28倍 | 0.63倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ハートシード | 145,000円 | +154.1% | - | 0.00% | - | 7.10倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
市場注目の銘柄
チャート関連のコラム
